American Conference Institute Disputes
Oct
7
2020
Date: October 7, 2020
Mintz is proud to sponsor the ACI Paragraph IV Disputes conference. Each year, leading pharmaceutical patent litigators for brand name and generic drug companies gather to discuss, debate, and analyze the latest trends, judicial rulings, and legislative developments affecting Hatch-Waxman litigation. Mintz Members, Kathleen Carr and
Mintz Member, Kathleen Carr, will be speaking on a panel entitled, “New Studies in Obviousness: Thoughts on Inherency, Structure, Prior Art and Secondary.”
Mintz Member, Dave Conlin, will be speaking on a session entitled, “Ethics and New Developments Impacting Professional Responsibility in the Hatch-Waxman Arena.”
Speakers
Kathleen B. Carr
Panelist
Kathleen B. Carr is a Mintz attorney with more than 20 years of experience as lead counsel on federal and state court cases. She has led trial teams on Hatch-Waxman pharmaceutical patent litigation, and she's registered to practice before the US Patent and Trademark Office.
David G. Conlin
Speaker
David G. Conlin helps plan, establish, maintain, and enforce clients’ intellectual property portfolios for Mintz. He assists clients with protecting their freedom to operate amid improperly alleged IP infringement, and his teams have driven the issuance of over 3,700 patents.